Omeros
Clinical Stage Bio
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.Homepage: http://www.omeros.com/
Total money raised: $63M
USA
Updated on Oct 27, 2010
Omeros at CrunchBase
Omeros at CrunchBase
October, 2010
Billionaire Allen helps inject $25M into Seattle's Omeros 
fiercebiotech.com
October, 2009
Omeros IPO
Stock symbol: OMER
February, 2007
Omeros raised $63M in a Series E round from Aravis Ventures, ARCH Venture Partners, The Grosvenor Funds, Novartis Venture Fund, Southern Cross Venture Partners, Stanley Medical Research Institute, Trevi Health Ventures, and WRF Capital
Omeros Raises More Than $63 Million in Financing 
investor.omeros.com